Literature DB >> 21909994

MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.

Si Li1, Zhu Liang, Liu Xu, Fangdong Zou.   

Abstract

MiRNAs are a new class of small RNA molecules that regulate gene expression at the post-transcriptional and translational levels. MiRNAs have been implicated in the control of many vital biological processes including development, cell proliferation, differentiation, and apoptosis. A growing number of studies have shown that miRNAs also play an important role in carcinogenesis and other diseases. Among the miRNAs identified, miRNA-21 is dramatically up-regulated in cancer cells of various origins. It regulates a wide range of genes and pathways involved in cancer initiation, transformation, invasion, and metastasis. MiRNA-21 also acts as a pro-survival factor in cardiovascular diseases. Aberrant expression in these diseases makes miRNA-21 a potential marker for disease diagnosis and prognosis. This review highlights the complex roles that miRNA-21 plays in cancer and cardiovascular diseases and its potential clinical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909994     DOI: 10.1007/s11010-011-1052-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  106 in total

1.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

2.  Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

Authors:  Rebecca T Marquez; Sarmistha Bandyopadhyay; Erik B Wendlandt; Kathy Keck; Brandon A Hoffer; Michael S Icardi; Randolph N Christensen; Warren N Schmidt; Anton P McCaffrey
Journal:  Lab Invest       Date:  2010-07-12       Impact factor: 5.662

3.  TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.

Authors:  Olav Gressner; Tobias Schilling; Katja Lorenz; Elisa Schulze Schleithoff; Andreas Koch; Henning Schulze-Bergkamen; Anna Maria Lena; Eleonora Candi; Alessandro Terrinoni; Maria Valeria Catani; Moshe Oren; Gerry Melino; Peter H Krammer; Wolfgang Stremmel; Martina Müller
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

4.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

5.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

6.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

7.  REST maintains self-renewal and pluripotency of embryonic stem cells.

Authors:  Sanjay K Singh; Mohamedi N Kagalwala; Jan Parker-Thornburg; Henry Adams; Sadhan Majumder
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

8.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

9.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

Authors:  Tao Li; Dong Li; Jianjun Sha; Peng Sun; Yiran Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

10.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

View more
  35 in total

1.  Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

Authors:  Suzan Schwertheim; Frederik Wein; Klaus Lennartz; Karl Worm; Kurt Werner Schmid; Sien-Yi Sheu-Grabellus
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-06       Impact factor: 4.553

2.  Differences in microRNA detection levels are technology and sequence dependent.

Authors:  Dena Leshkowitz; Shirley Horn-Saban; Yisrael Parmet; Ester Feldmesser
Journal:  RNA       Date:  2013-02-19       Impact factor: 4.942

3.  Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.

Authors:  Alicia Báez; Beatriz Martín-Antonio; José I Piruat; Concepción Prats; Isabel Álvarez-Laderas; M Victoria Barbado; Magdalena Carmona; Álvaro Urbano-Ispizua; Jose Antonio Pérez-Simón
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

4.  Antischistosomiasis Liver Fibrosis Effects of Chlorogenic Acid through IL-13/miR-21/Smad7 Signaling Interactions In Vivo and In Vitro.

Authors:  Yao Wang; Fan Yang; Jun Xue; Xuan Zhou; Lei Luo; Qian Ma; Yun-Fei Chen; Juan Zhang; Shu-Ling Zhang; Lei Zhao
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21.

Authors:  Changwen Jing; Haixia Cao; Xiaobing Qin; Shaorong Yu; Jianzhong Wu; Zhuo Wang; Rong Ma; Jifeng Feng
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

6.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

7.  MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Authors:  Z Bing; S R Master; J W Tobias; D A Baldwin; X W Xu; J E Tomaszewski
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

Review 8.  MicroRNA expression in hepatitis C virus-related malignancies: A brief review.

Authors:  Laura Gragnani; Alessia Piluso; Elisa Fognani; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

9.  MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.

Authors:  Na Wang; Chao-Qi Zhang; Jia-Huan He; Xiao-Fei Duan; Yuan-Yuan Wang; Xiang Ji; Wen-Qiao Zang; Min Li; Yun-Yun Ma; Tao Wang; Guo-Qiang Zhao
Journal:  Dig Dis Sci       Date:  2013-03-17       Impact factor: 3.199

10.  Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.

Authors:  Colleen M Connelly; Robert E Boer; Michelle H Moon; Peter Gareiss; John S Schneekloth
Journal:  ACS Chem Biol       Date:  2016-12-23       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.